Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates - 2

无症状颈动脉狭窄:认知功能和斑块相关 - 2

基本信息

  • 批准号:
    9932930
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-07-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Vascular cognitive impairment is an insidious disease resulting from accumulated ischemic injury to the brain. Our VA Merit-funded Asymptomatic Carotid Stenosis and Cognitive Function (ACCOF) found that in the setting of carotid stenosis, alterations of behavior can occur in the absence of physical manifestations of stroke. Otherwise asymptomatic patients with carotid stenosis had worse cognitive performance than controls. In addition, approximately 40% of patients with stenosis had cerebral hemodynamic compromise at baseline; and hemodynamic compromise correlated with cognitive impairment. Not all patients with carotid stenosis have reduced cerebral perfusion. The geometry of the plaque (degree of stenosis, length and shape of the plaque) and, as we have demonstrated, the extent of intra-cerebral collateralization across the Circle of Willis, influence cerebral perfusion. The implication of these findings is that a subset of carotid stenosis patients has hemodynamic compromise, and that reversal of the hemodynamic abnormalities by removing the stenosis may ameliorate the associated cognitive impairment. Therefore, treatment for carotid stenosis might need to be broadened to include preservation of cognition-related Quality of Life (QoL). The demonstration that some patients with carotid stenosis are living with reversible cognitive impairment would have important public-health implications. Carotid stenosis affects 2-12% of people. With 23 million Veterans in the country, approximately 1 million (4.3%) will have a stenosis. ACCOF shows that these patients are at risk for cognitive impairment which, with intervention, might be reversible. We propose a longitudinal controlled observational study that assesses whether carotid revascularization improves cognitive dysfunction in patients with cerebral hemodynamic compromise. Proof of concept (followed by a clinical trial) is necessary before a shift in clinical practice is considered. If cognitive decline can be reversed in these patients, we will have established a new indication for carotid revascularization independent of stroke prevention. We will enroll 138 patients with asymptomatic high-grade (≥70%) carotid stenosis undergoing planned carotid endarterectomy. Approximately 40% (n=55 patients) of patients are anticipated to have compromised cerebral perfusion at baseline (study group); the remaining 60% (n=83) will have carotid stenosis but will not have compromised perfusion (control group). Our Primary Aim will determine if carotid revascularization improves cognitive performance at 1 year in patients with cerebral hemodynamic compromise at baseline. We hypothesize that among patients with asymptomatic carotid stenosis undergoing carotid endarterectomy, cognitive performance will improve more in those with impaired cerebral perfusion at baseline versus those with normal baseline perfusion. Our Secondary Aim 1 will determine whether cerebral hemodynamic compromise is the result of pressure drop across the carotid artery stenosis. We hypothesize that among all patients enrolled, the degree of PWI-TTP delay at baseline will correlate with the degree of pressure drop across the carotid stenosis. Pressure drop will be measured by patient-specific computational fluid dynamic modeling based on 3D imaging of carotid luminal geometry, flow measurements, and analysis of the circulation in the Circle of Willis. Secondary Aim 2 will determine whether cognitive improvement after revascularization is the result of improved cerebral hemodynamics. We hypothesize that among patients with delayed PWI-TTP at baseline, the degree of improvement in cognition after revascularization will correlate with the improvement in pressure drop. Secondary Aim 3 will determine whether differences in cognitive outcome between the two groups impact quality of life. We hypothesize that 1 year after revascularization, quality of life will improve more in patients with impaired baseline cerebral perfusion versus those without impairment.
血管性认知功能障碍是一种由脑缺血累积性损伤引起的潜伏性疾病 大脑。我们由退伍军人事务部资助的无症状颈动脉狭窄和认知功能(ACCOF)发现,在 颈动脉狭窄的背景下,在没有生理表现的情况下,可以发生行为改变 卒中。此外,无症状的颈动脉狭窄患者的认知表现比对照组更差。 此外,约40%的狭窄患者在基线时有脑血流动力学障碍; 血流动力学折衷与认知损害相关。并不是所有的颈动脉狭窄患者 大脑灌注量减少。斑块的几何形状(狭窄程度、斑块长度和形状) 正如我们已经证明的,威利斯环脑内侧支循环的影响程度 脑血流灌注。 这些发现的含义是颈动脉狭窄患者中的一部分具有血流动力学。 且通过移除狭窄来逆转血流动力学异常可以 改善相关的认知障碍。因此,颈动脉狭窄的治疗可能需要 扩大到包括与认知相关的生活质量(QOL)的保存。证明了一些人 颈动脉狭窄患者患有可逆性认知障碍将有重要的公共健康 这意味着什么。2-12%的人会受到颈动脉狭窄的影响。这个国家有2300万退伍军人,大约 100万人(4.3%)将出现狭窄。ACCOF显示,这些患者存在认知障碍的风险 如果进行干预,这可能是可逆的。 我们提出了一项纵向对照观察性研究,评估颈动脉血运重建 改善脑血流动力学受损患者的认知功能障碍。概念验证(遵循 临床试验)是必要的,然后才考虑临床实践的转变。如果认知能力下降可以 在这些患者中,我们将建立一个独立于颈动脉血运重建的新指征 预防中风。我们将招募138名无症状的高度颈动脉狭窄(≥70%)患者 正在接受计划中的颈动脉内膜切除术。大约40%(n=55名患者)的患者预计会 脑血流灌注在基线水平受损(研究组);其余60%(n=83)将有颈动脉 狭窄但不影响血流灌注(对照组)。 我们的主要目标将确定颈动脉血运重建术是否能在1岁时改善认知能力 患者的脑血流动力学在基线水平上有所下降。我们假设,在患有 接受颈动脉内膜切除术的无症状颈动脉狭窄患者,认知能力将得到更大改善 基线脑血流灌注受损者与基线脑血流灌注正常者比较。我们的 次要目标1将确定脑血流动力学损害是否是压力下降的结果 穿过颈动脉狭窄。我们假设在所有入选的患者中,PWI-TTP的程度 基线延迟将与颈动脉狭窄的压力下降程度相关。压降将 通过基于颈动脉腔三维成像的特定患者计算流体动力学模型进行测量 威利斯环流的几何、流量测量和分析。次要目标2将 确定血运重建后的认知改善是否是大脑功能改善的结果 血流动力学。我们假设在基线时PWI-TTP延迟的患者中, 血运重建后认知功能的改善将与压降的改善相关。 次要目标3将确定两组之间认知结果的差异是否会影响 生活质量。我们假设在血运重建1年后,患者的生活质量将得到更多的改善。 基线脑血流灌注受损者与无受损者比较。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brajesh K Lal其他文献

Brajesh K Lal的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brajesh K Lal', 18)}}的其他基金

Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates - 2
无症状颈动脉狭窄:认知功能和斑块相关 - 2
  • 批准号:
    9522798
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates - 2
无症状颈动脉狭窄:认知功能和斑块相关 - 2
  • 批准号:
    9348890
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome
新型运动计划对预防血栓后综合症的作用
  • 批准号:
    8677016
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome
新型运动计划对预防血栓后综合症的作用
  • 批准号:
    9071859
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates
无症状颈动脉狭窄:认知功能和斑块相关
  • 批准号:
    8043407
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates
无症状颈动脉狭窄:认知功能和斑块相关
  • 批准号:
    8392973
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates
无症状颈动脉狭窄:认知功能和斑块相关
  • 批准号:
    8698365
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates
无症状颈动脉狭窄:认知功能和斑块相关
  • 批准号:
    8282617
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了